2.
CRABPII和E-FABP在NSCLC原发癌中的表达与临床病理特征的关系
Relationship between expression of CRABPII and E-FABP and clinicopathological characteristics of NSCLC
| Characteristic | n | CRABPII | P | E-FABP | P | ||
| (–) | (+)-(+++) | (–) | (+)-(+++) | ||||
| Gender | 0.019 | 0.726 | |||||
| Male | 230 | 148 | 82 | 95 | 135 | ||
| Female | 57 | 27 | 30 | 25 | 32 | ||
| Age (year) | 0.320 | 0.416 | |||||
| ≤61 | 154 | 98 | 56 | 61 | 93 | ||
| > 61 | 133 | 77 | 56 | 59 | 74 | ||
| Tumor size | 0.336 | 0.835 | |||||
| Diameter ≤3 cm | 108 | 62 | 46 | 46 | 62 | ||
| Diameter > 3 cm | 179 | 113 | 66 | 74 | 105 | ||
| Histological type | 0.157 | 0.809 | |||||
| Squamous cell carcinoma | 133 | 89 | 44 | 58 | 75 | ||
| Adenocarcinoma | 126 | 70 | 56 | 50 | 76 | ||
| Adenosquamous carcinoma | 28 | 16 | 12 | 12 | 16 | ||
| Grading | 0.060 | 0.001 | |||||
| Well | 13 | 4 | 9 | 6 | 7 | ||
| Moderate | 144 | 89 | 55 | 45 | 99 | ||
| Poor | 102 | 66 | 36 | 57 | 45 | ||
| Metastasis | 0.004 | 0.019 | |||||
| Yes | 143 | 99 | 44 | 50 | 93 | ||
| No | 144 | 76 | 68 | 70 | 74 | ||
| TNM staging | 0.004 | 0.531 | |||||
| Ⅰ+Ⅱ | 154 | 82 | 72 | 67 | 87 | ||
| Ⅲ+Ⅳ | 133 | 93 | 40 | 53 | 80 | ||